<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01070277</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-08-5059-ES-CTIL</org_study_id>
    <nct_id>NCT01070277</nct_id>
  </id_info>
  <brief_title>Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study hypotheses is that Antiparasitic therapy in patients with chronic diarrhea after travel
      to a developing country, with a negative stool findings, will be significantly effective in
      eliminating diarrhea and other gastro-intestinal complaints compared to similar patients
      receiving placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is common to encounter travelers from developing countries who suffer from persistent
      diarrhea after returning home. In many cases repeated stool samples are negative for
      bacteria, parasites and helminthes and the cause of the diarrhea is not found.

      The main debate is whether this condition is a persistent parasitic infection (unidentified)
      or post-infectious irritable bowel syndrome.However, clinical experience suggests that some
      of these travelers respond to antiparasitic therapy.

      This study aims to answer the question whether antiparasitic treatment in these cases is
      beneficial.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>improvement in gastrointestinal complaints</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Chronic Diarrhea</condition>
  <condition>Abdominal Pain</condition>
  <condition>Bloating</condition>
  <arm_group>
    <arm_group_label>Placebo arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 placebo pills X2 /day for 2 days followed by
1 placebo Pill X2 / day for 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tinidazole and Albendazole treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tinidazole 1 gram BID for 2 days followed by Albendazole 400mg BID for 7 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tinidazole and Albendazole</intervention_name>
    <description>Tinidazole 2 gr/daily for 2 days followed by Albendazole 400mg X2 /day for 7 days</description>
    <arm_group_label>Tinidazole and Albendazole treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo control</intervention_name>
    <description>2 placebo pills X2 /day for 2 days followed by
1 placebo Pill X2 / day for 7 days</description>
    <arm_group_label>Placebo arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diarrhea (3 or more soft stools per day) for at least two weeks after a trip to a
             developing country in the past year

          -  Stool sample negative for bacteria, parasites and helminthes at least once

          -  Has not received, until now, antiparasitic or antihelminthic therapy

        Exclusion Criteria:

          -  Bloody diarrhea

          -  Fever during enrolment 5. Allergy to the offered medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center, Tel Hashomer, Israel</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eli Schwartz, MD</last_name>
      <phone>++97235308456</phone>
      <email>elischwa@post.tau.ac.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat-Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eli Schwartz, M.D</last_name>
      <phone>+972-35308456</phone>
      <email>Eli.schwartz@sheba.health.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2010</study_first_submitted>
  <study_first_submitted_qc>February 17, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2010</study_first_posted>
  <last_update_submitted>August 26, 2014</last_update_submitted>
  <last_update_submitted_qc>August 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Prof. Eli Schwartz MD, DTMH</investigator_full_name>
    <investigator_title>Director, The Center of Geographic Medicine</investigator_title>
  </responsible_party>
  <keyword>chronic diarrhea</keyword>
  <keyword>travelers</keyword>
  <keyword>Parasites</keyword>
  <keyword>albendazole</keyword>
  <keyword>tinidazole</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Abdominal Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albendazole</mesh_term>
    <mesh_term>Tinidazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

